| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 21271-30-7 | Acetic acid,2-[(4-oxo-3-phenyl-4H-pyrazino[1,2-a]pyrimidin-2-yl)oxy]-, ethyl ester; Aceticacid, [(4-oxo-3-phenyl-4H-pyrazino[1,2-a]pyrimidin-2-yl)oxy]-, ethyl ester(8CI) |  | C17H15N3O4 | 詳情 | 供應商 | |
| 42784-13-4 | Carbamic acid,[1-(phenoxyacetyl)-1H-benzimidazol-2-yl]-, methyl ester (9CI); Benacyl |  | C17H15N3O4 | 詳情 | 供應商 | |
| 158846-25-4 | Carbamic acid,[1-(3-methoxybenzoyl)-1H-benzimidazol-2-yl]-, methyl ester (9CI); IPO 4612 |  | C17H15N3O4 | 詳情 | 供應商 | |
| 156074-06-5 | L-Alanine,N-(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)-, hydrazide; NU/ICRF 502 |  | C17H15N3O4 | 詳情 | 供應商 | |
| 24143-26-8 | Oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one,2,3,7,11b-tetrahydro-10-nitro-11b-phenyl- |  | C17H15N3O4 | 詳情 | 供應商 | |
| 29442-58-8 | 2H-1,4-Benzodiazepin-2-one,1,3-dihydro-1-(methoxymethyl)-7-nitro-5-phenyl-; Motrazepam; NSC 313451; Ro 06-9098 |  | C17H15N3O4 | 詳情 | 供應商 |